Dr. Saumya Pandey (M.Sc. Biochemistry, Ph.D. Life Science), constantly endeavors to contribute meaningfully to the ever-expanding clinical research field with an emphasis on high-quality ethical scientific research with adherence to core tenets of bioethics and scientific integrity. I have a competitive publication track of 54 first authorships including 48 senior authorships (56 publications/cumulative IF=263.27) in leading international journals along with expert Peer-Reviewer Recognition awards in translational research. I have earned 56 academic credits from Graduate Schools of Biomedical Sciences, Schools of Medicine, University of Texas Medical Branch, Galveston, Texas, USA, and Creighton University, Omaha, Nebraska, the USA with evidence-based clinical/clinical research observerships at New York Presbyterian-Weill Cornell Medical and Cold Spring Harbor Laboratory, New York, USA; further, I gained my healthcare-business management/strategy certificates from Harvard and Wharton Business Schools, USA. My areas of clinical research interests span Molecular Medicine, Immunobiology of Human Diseases, Electrophysiology, Neurodegenerative Diseases, Allergic Airway Inflammation/Asthma, Cardiovascular Diseases: Atherosclerosis/Neointimal-Hyperplasia/Restenosis, Oncology: HPV-mediated Cervical Cancer, Breast Cancer, Gastric, Colorectal, and Hepatocellular Carcinomas, Prostate Cancer and Glioblastoma, Oncofertility and Health Disparities/Epidemiology, Obstetrics-Gynecology, Gynecologic Endocrinology, Reproductive Medicine: Female/Male Infertility and Urology/Sexual Medicine. I have successfully presented my innovative biomedical and public health research at the prestigious Keystone Symposia, Silverthorne, Colorado, USA, and American Society of Reproductive Medicine, Washington D.C./Birmingham, Alabama, USA scientific sessions during the current Covid-19/Omicron global pandemic. I have previously served as Faculty-Research/Science-Technology at Amity University Uttar Pradesh, Lucknow, India, and recently completed my assignment as Head-Clinical Research at a reputed India-based Fertility Hospital; with my inherent interest in impactful clinical/scientific research, teaching, mentoring, publishing and reviewing, I strongly believe in target-driven pragmatic scientific goals for achieving highest level(s) of academic excellence and eventual enriching scientific publishing and peer-reviewing experience for elegantly disseminating innovative clinical medicine and scientific concepts on a global platform.
Dr. Saumya Pandey is a reputed clinical/translational/biomedical research expert with particular emphasis on gastroenterology/hepatology and carcinogenesis in the complex digestive tract and hepatobiliary system. In my expert opinion, immunotherapeutic targeting of complex biochemical/metabolic signaling networks primarily Toll-like Receptors-Autophagy-Wnt in dissecting the cellular/molecular/genetic basis of hepatobiliary/gastric ailments/diseases viz. aberrant physiologic milieu-related inflammation, viral hepatitis, gastric and/or hepatocellular and colorectal carcinomas in ethnically disparate population-subsets, in the current Covid-19/Omicron global pandemic era, offers fascinating immunopharmacological/therapeutic avenues for the development of predictive biomarkers, design of pharmacological scaffolds and novel drugs in evidence-based risk-stratification and disease management.